The following data is part of a premarket notification filed by Jms North America Corporation with the FDA for Neoshield.
Device ID | K172499 |
510k Number | K172499 |
Device Name: | NEOSHIELD |
Classification | Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System |
Applicant | JMS North America Corporation 22320 Foothill Blvd. Suite 350 Hayward, CA 94541 |
Contact | Sho Hosoki |
Correspondent | Yolanda Smith Smith Assoicates 1468 Harwell Ave Crofton, MD 21114 |
Product Code | ONB |
CFR Regulation Number | 880.5440 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2017-08-18 |
Decision Date | 2018-06-01 |
Summary: | summary |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NEOSHIELD 97172624 not registered Live/Pending |
MMI-IPCO, LLC 2021-12-14 |
NEOSHIELD 88336793 not registered Live/Pending |
Wheel Group Holdings, LLC 2019-03-12 |
NEOSHIELD 85883963 4418662 Live/Registered |
JMS CO., LTD. 2013-03-22 |
NEOSHIELD 79280424 not registered Live/Pending |
Glanbia PLC 2020-01-17 |
NEOSHIELD 75350155 not registered Dead/Abandoned |
BAYER CORPORATION 1997-09-02 |